Intellia Therapeutics Ownership | Who Owns Intellia Therapeutics?
Intellia Therapeutics Ownership Summary
Intellia Therapeutics is owned by 122.40% institutional investors, 3.86% insiders. Ark investment management is the largest institutional shareholder, holding 14.24% of NTLA shares. ARK Disruptive Innovation Full Composite is the top mutual fund, with 7.96% of its assets in Intellia Therapeutics shares.
NTLA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Intellia Therapeutics | 122.40% | 3.86% | -26.26% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ark investment management | 16.88M | 14.24% | $285.54M |
| Blackrock funding, inc. /de | 15.41M | 13.00% | $260.72M |
| Vanguard group | 13.01M | 11.81% | $116.96M |
| Blackrock | 9.60M | 10.05% | $214.79M |
| State street | 7.81M | 5.85% | $94.18M |
| D. e. shaw | 6.44M | 5.44% | $109.02M |
| Vanguard capital management | 6.03M | 5.09% | $102.00M |
| Two sigma investments, lp | 5.24M | 4.42% | $88.58M |
| Ra capital management | 4.53M | 3.82% | $76.60M |
| Fmr | 4.69M | 3.52% | $56.59M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Regeneron pharmaceuticals | 3.70M | 24.86% | $44.66M |
| Birchview capital, lp | 385.90K | 3.17% | $6.78M |
| Contrarius investment management | 1.92M | 2.68% | $42.87M |
| Ark investment management | 16.88M | 1.85% | $285.54M |
| Contrarius group | 2.43M | 1.43% | $29.33M |
| Orchard capital management | 79.50K | 1.31% | $1.35M |
| Deuterium capital management | 100.00K | 1.29% | $1.21M |
| Scientech research | 72.53K | 0.99% | $1.23M |
| Iq eq fund management (ireland) | 777.95K | 0.84% | $13.16M |
| Ra capital management | 4.53M | 0.67% | $76.60M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | 4.53M | 0.67% | 4.53M |
| Blackrock funding, inc. /de | 15.41M | 0.00% | 3.25M |
| Ark investment management | 16.88M | 1.85% | 2.37M |
| Vanguard group | 13.01M | 0.00% | 1.97M |
| Arrowstreet capital, limited partnership | 3.28M | 0.02% | 1.88M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | - | - | -4.95M |
| Capital investors | - | - | -3.78M |
| State street | 7.81M | 0.00% | -1.43M |
| Rokos capital management llp | - | - | -1.14M |
| Ubs group | 1.25M | 0.00% | -905.61K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ra capital management | 4.53M | 0.67% | 4.53M | $76.60M |
| Sixth street partners management company | 1.21M | 0.00% | 1.21M | $20.44M |
| Ghisallo capital management | 1.20M | 0.40% | 1.20M | $20.30M |
| Baker bros. advisors lp | 930.23K | 0.08% | 930.23K | $15.74M |
| Farallon capital management | 607.20K | 0.04% | 607.20K | $10.49M |
Sold Out
| Holder | Change |
|---|---|
| Dinuzzo private wealth | -1.00 |
| Corecap advisors | -1.00 |
| Activest wealth management | -1.00 |
| Global financial private client | -1.00 |
| Richard w. paul & associates | -2.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 350 | 9.03% | 145,029,744 | 31.34% | 122 | 1.18% | 194 | 0.52% | 81 | 26.56% |
| Mar 31, 2026 | 218 | -31.01% | 72,199,779 | -30.72% | 66 | 0.74% | 127 | -22.09% | 42 | -53.33% |
| Dec 31, 2025 | 221 | -28.25% | 80,835,304 | -22.43% | 73 | 0.82% | 102 | -32.45% | 72 | -10.00% |
| Sep 30, 2025 | 289 | 1.05% | 103,222,255 | 12.82% | 99 | 1.28% | 143 | -2.72% | 76 | -8.43% |
| Jun 30, 2025 | 290 | -7.05% | 98,735,343 | -2.49% | 95 | 0.99% | 146 | -0.68% | 85 | -10.53% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Disruptive Innovation Full Composite | 11.13M | 7.96% | 1.82M |
| ARK Innovation ETF | 10.99M | 7.84% | -357.80K |
| American Funds SMALLCAP World A | 3.78M | 3.65% | 3.78M |
| State Street® SPDR® S&P® Biotech ETF | 4.60M | 3.28% | 120.38K |
| Vanguard MStar Total Stk Mkt Idx Invest | 4.32M | 3.08% | 18.66K |
| Vanguard Total Stock Mkt Idx Inv | 4.29M | 3.07% | -18.46K |
| Vanguard Morn Total Stk Mkt Idx Investor | 4.29M | 3.07% | -18.46K |
| Vanguard US Total Market Shares ETF | 3.17M | 3.06% | 299.88K |
| iShares Russell 2000 ETF | 3.50M | 2.49% | - |
| ARK Genomic Revolution ETF | 3.40M | 2.43% | 19.60K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 02, 2026 | LEONARD JOHN M | President and CEO | Sell | $107.91K |
| Oct 02, 2026 | Dube Michael P | VP, Chief Accounting Officer | Sell | $23.17K |
| Aug 20, 2026 | LEONARD JOHN M | President and CEO | Sell | $250.61K |
| Aug 21, 2026 | LEONARD JOHN M | President and CEO | Sell | $36.20K |
| Jul 22, 2026 | Dulac Edward J III | EVP, Chief Financial Officer | Sell | $91.25K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | 2 |
| 2026 Q3 | - | 5 |
| 2026 Q2 | - | - |
| 2026 Q1 | 1 | 9 |
| 2025 Q4 | - | 5 |
NTLA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools